Sale

Cell Therapy Market

Global Cell Therapy Market Size, Growth, Trends, Research: By Cell Type: Stem Cell, Non-Stem Cell; By Therapy Type: Autologous, Allogeneic; By Therapeutic Area: Musculoskeletal disorders, Cardiovascular diseases, Neurological disorders, Oncological disorders, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Cell Therapy Market Outlook

The global cell therapy market value was USD 16.30 billion in 2023, driven by the increasing demand for regenerative therapies structure across the globe. The market size is anticipated to grow at a CAGR of 18.1% during the forecast period of 2024-2032 to achieve a value of USD 72.84 billion by 2032.

 

Global Cell Therapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Use of Cell Therapies to Treat Severe COVID-19 Patients to Boost the Growth of the Cell Therapy Industry

The global market for cell therapy is  being driven by the increasing research and development (R&D) activities in the medical industry. Cell therapy is increasingly being used to treat patients with cancer, weakened immune systems, infectious diseases, and neurological disorders, which, in turn, surging its demand. Further, the COVID-19 pandemic is expected to positively impact the pharmaceutical and biotechnology-based research projects, including cell therapy. As the SARS-CoV-2 virus critically damages the lungs and immune system of the infected patient, various cell therapies are increasingly being explored as a potential treatment for the novel disease. Moreover, cell therapy can substantially improve survival rates of end-stage patients with acute respiratory distress syndrome (ARSD) associated with SARS-CoV-2, which is providing further impetus to the industry growth.

 

Europe Represents a Significant Regional Market for Cell Therapy Due to the Rising R&D Activities

Europe holds a significant share of the overall cell therapy industry, with France and the United Kingdom  being some of the dominant regional markets. The increasing research and development activities in France, owing to the presence of some of the leading biotech and research institutions of cell therapy, are aiding the market growth. In addition, the French biotech institutions, with government aid, are contributing to the development of innovative cell therapies. Moreover, the introduction of various favourable government initiatives to aid research activities is invigorating the industry growth, hence contributing to the overall market growth in the European region. For instance, the United Kingdom government initiated the Human-Induced Pluripotent Stem Cells Initiative (HipSCi) to bring preclinical, clinical and pharmacological work on stem cells under one institution and increase the accessibility of induced pluripotent stem cell (iPSC) resources to identify new mechanisms.

 

Cell Therapy: Industry  Definition and Segmentation

Cell therapy refers to a medical treatment in which ailing or dysfunctional cells are replaced with healthy and functional cells. The therapy aims at reducing or curing symptoms of diseases by restoring and altering certain sets of cells or by using cells to carry a remedy through the body. These cells may either be derived from the patient (autologous cells) or a donor (allogeneic cells). The cells are cultivated outside the body before transplanting into the patient.

 

Global Cell Therapy Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the market is divided into:

  • Autologous
  • Allogeneic

On the basis of therapy, the cell therapy industry is categorised into:

  • Mesenchymal Stem Cell Therapy
  • Fibroblast Cell Therapy
  • Haematopoietic Stem Cell Therapy

Based on application, the market is segmented into:

  • Musculoskeletal
  • Malignancies
  • Cardiovascular
  • Dermatology and Wounds

The EMR report looks into the regional market of cell therapy like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

 

Global Cell Therapy Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Investments in Infrastructure and Technology of Cell Therapy to Augment the Market Growth

With the growth in discoveries and innovations taking place around the globe, the healthcare sector is flourishing rapidly, which, in turn, is aiding the growth of the cell therapy industry. Cell therapies are becoming an ideal choice for treatment due to their high success rate, which is expected to fuel the market growth further. Various innovative cell therapies are emerging as a promising treatment for cancer and other diseases and are supporting the overall market growth. Increasing investments in the field of cell therapy, growing technological advancements, and rising cases of diseases such as cancer and cardiac abnormalities are also driving the growth of the industry.

The rapid expansion of the cell therapy industry to enhance the accessibility and functionality of cell therapies while reducing toxicity is anticipated to propel the market growth. The development of effective treatment of solid tumours  is likely to be another breakthrough for cell-based therapies, which is expected to  positively impact the market development in the coming years. Furthermore, the increasing investments for the research and development (R&D) activities to minimise costs during the manufacturing process while eliminating the requirement of a specialised structure is estimated to invigorate the growth of the cell therapy industry. The potential for cell therapy to treat major diseases such as cancer, anaemia, and Alzheimer’s disease, among others, is projected to further strengthen the cell therapy industry in the forecast period.

 

Key Industry Players in the Global Cell Therapy Market

The report presents a detailed analysis of the following key players in the global cell therapy market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions.

  • Tego Science
  • Chiesi Farmaceutici S.p.A
  • Pharmicell Co., Ltd
  • Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

 

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Cell Type
  • Therapy Type
  • Therapeutic Area
  • End User
  • Region
Breakup by Cell Type
  • Stem Cell
  • Non-Stem Cell
Breakup by Therapy Type
  • Autologous
  • Allogeneic
Breakup by Therapeutic Area
  • Musculoskeletal disorders
  • Cardiovascular diseases
  • Neurological disorders
  • Oncological disorders
  • Dermatology
  • Inflammatory and Autoimmune disorders
  • Others
Breakup by End User
  • Hospitals and Clinics
  • Regenerative Medicine Centers
  • Diagnostic and Research Centers
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Vericel Corporation
  • Kolon TissueGene Inc.
  • JCR Pharmaceuticals Co. Ltd.
  • MEDIPOST Co. Ltd.
  • Osiris
  • Stemedica Cell Technologies Inc.
  • NuVasive Inc.
  • Fibrocell Science Inc.
  • PHARMICELL Co. Ltd
  • ANTEROGEN.CO.LTD.
  • Novartis AG,
  • CELGENE CORPO    RATION
  • Allogene Therapeutics Inc.
  • Stempeutics Research Pvt. Ltd

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope
    1.4    Research Methodology
2    Executive Summary
3    Global Cell Therapy Market Overview 

    3.1    Global Cell Therapy Market Historical Value (2017-2023) 
    3.2    Global Cell Therapy Market Forecast Value (2024-2032)
4    Global Cell Therapy Market Landscape
    4.1    Global Cell Therapy Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cell Therapy Product Landscape
        4.2.1    Analysis by Cell Type
        4.2.2    Analysis by Therapy Antigen
        4.2.3    Analysis by End User
5    Global Cell Therapy Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Cell Therapy Market Segmentation
    6.1    Global Cell Therapy Market by Cell Type
        6.1.1    Market Overview
        6.1.2    Stem Cell
            6.1.2.1    Bone Marrow
            6.1.2.2    Blood
            6.1.2.3    Umbilical Cord
            6.1.2.4    Adipose Derived Stem Cell
            6.1.2.5    Others (Placenta, and Non-Specific Cells)
        6.1.3    Non-Stem Cell
    6.2    Global Cell Therapy Market by Therapy Type
        6.2.1    Market Overview
        6.2.2    Autologous
        6.2.3    Allogeneic
    6.3    Global Cell Therapy Market by Therapeutic Area
        6.3.1    Market Overview
        6.3.2    Musculoskeletal disorders
        6.3.3    Cardiovascular diseases
        6.3.4    Neurological disorders
        6.3.5    Oncological disorders
        6.3.6    Dermatology
        6.3.7    Inflammatory and Autoimmune disorders
        6.3.8    Others
    6.4    Global Cell Therapy Market by End User
        6.4.1    Market Overview
        6.4.2    Hospitals and Clinics
        6.4.3    Regenerative Medicine Centers
        6.4.4    Diagnostic and Research Centers
        6.4.5    Others
    6.5    Global Cell Therapy Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Cell Therapy Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Cell Therapy Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Cell Therapy Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Cell Therapy Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Cell Therapy Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization
14    Clinical Trials Analysis
    14.1     Analysis by Trial Registration Year 
    14.2    Analysis by Trial Status 
    14.3    Analysis by Trial Phase 
    14.4    Analysis by Therapeutic Area 
    14.5    Analysis by Geography  
15    Funding Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Supplier Landscape
    18.1    Vericel Corporation
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications
    18.2    Kolon TissueGene Inc.
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    JCR Pharmaceuticals Co. Ltd.
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    MEDIPOST Co. Ltd.
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Osiris
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Stemedica Cell Technologies Inc.
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7     NuVasive Inc.
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Fibrocell Science Inc.
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
        18.8.6    Cells for Cells
        18.8.7    Financial Analysis
        18.8.8    Product Portfolio
        18.8.9    Demographic Reach and Achievements
        18.8.10    Mergers and Acquisitions
        18.8.11    Certifications
    18.9    PHARMICELL Co. Ltd
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    ANTEROGEN.CO.LTD.
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
    18.11    Novartis AG, 
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Mergers and Acquisitions
        18.11.5    Certifications
    18.12    CELGENE CORPO    RATION
        18.12.1    Financial Analysis
        18.12.2    Product Portfolio
        18.12.3    Demographic Reach and Achievements
        18.12.4    Mergers and Acquisitions
        18.12.5    Certifications
    18.13    Allogene Therapeutics Inc.
        18.13.1    Financial Analysis
        18.13.2    Product Portfolio
        18.13.3    Demographic Reach and Achievements
        18.13.4    Mergers and Acquisitions
        18.13.5    Certifications
    18.14    Stempeutics Research Pvt. Ltd
        18.14.1    Financial Analysis
        18.14.2    Product Portfolio
        18.14.3    Demographic Reach and Achievements
        18.14.4    Mergers and Acquisitions
        18.14.5    Certifications
19    Global Cell Therapy Market - Distribution Model (Additional Insight)
    19.1    Overview 
    19.2    Potential Distributors 
    19.3    Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)
21    Company Competitiveness Analysis (Additional Insight)

    21.1    Very Small Companies
    21.2    Small Companies
    21.3    Mid-Sized Companies
    21.4    Large Companies
    21.5    Very Large Companies
22    Payment Methods (Additional Insight)
    22.1    Government Funded
    22.2    Private Insurance
    22.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global cell therapy market was valued at USD 16.30 billion in 2023.

The market is expected to grow at a CAGR of 18.1% from 2024 to 2032 to reach a value of USD 72.84 billion by 2032.

The cell therapy industry is being aided by the introduction of various favourable government initiatives and the rising investment in the healthcare sector for the integration of technological advancements in biotechnological researches.

The industry is anticipated to be driven by the use of cell therapies as effective COVID-19 and cancer treatments, the rising cost-effectiveness of cell therapy, and the increasing investments in research and development (R&D) activities.

The major regions in the industry are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

The major types of cell therapy in the market are autologous and allogeneic.

Mesenchymal stem cell therapy, fibroblast cell therapy, and hematopoietic stem cell therapy are the leading therapy segments in the cell therapy industry.

The significant application segments of cell therapy in the market are musculoskeletal, malignancies, cardiovascular, and dermatology and wounds.

They key players in the market are Tego Science, Chiesi Farmaceutici S.p.A, and Pharmicell Co., Ltd, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER